Global access to affordable CFTR modulator drugs: Time for action!

被引：9

作者：

Zampoli, Marco ^{[1
]}

Kashirskaya, Nataliya ^{[2
]}

Karadag, Bulent ^{[3
]}

Ribeiro Ferreira da Silva Filho, Luiz Vicente ^{[4
]}

Paul, Grace R. ^{[5
]}

Noke, Christine ^{[6
]}

机构：

[1] Univ Cape Town, Dept Paediat & Child Hlth, Natl Director South African CF Registry Steering, Cyst Fibrosis Clin,Red Cross War Mem Childrens Ho, Cape Town, South Africa

[2] Moscow Reg Res & Clin Inst, All Russian Assoc Patients Cyst Fibrosis, Lab Genet Epidemiol Res Ctr Med Genet, Moscow, Russia

[3] Marmara Univ, Div Pediat Pulmonol, Istanbul, Turkey

[4] HCFMUSP, Pediat Pulmonol Unit, Sao Paulo, Brazil

[5] Ohio State Univ, Nationwide Childrens Hosp, Div Pulm & Sleep Med, Columbus, OH USA

[6] Middle East Cyst Fibrosis Assoc MECFA, Chestnut Hill, MA USA

来源：

JOURNAL OF CYSTIC FIBROSIS | 2022年 / 21卷 / 03期

关键词：

D O I：

10.1016/j.jcf.2022.03.006

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：E215 / E216

页数：2

共 5 条

[1] Worldwide rates of diagnosis and effective treatment for cystic fibrosis [J].

Guo, Jonathan ;

Garratt, Anna ;

Hill, Andrew .

JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (03) :456-462

[2]

investors.vrtx, VERT PHARM FIN REP

[3] CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine [J].

Lopes-Pacheco, Miqueias .

FRONTIERS IN PHARMACOLOGY, 2020, 10

[4]

medicinespatentpool, MED PAT TOOL

[5] Projecting the impact of delayed access to elexacaf tor/tezacaf tor/ivacaf tor for people with Cystic Fibrosis * [J].

Stanojevic, Sanja ;

Vukovojac, Katarina ;

Sykes, Jenna ;

Ratjen, Felix ;

Tullis, Elizabeth ;

Stephenson, Anne L. .

JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (02) :243-249

← 1 →